161 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
will have the option to engage (at its own expense, except as otherwise provided below) an independent internationally-recognized certified public … the batch which is in dispute will promptly be submitted for testing and evaluation to an independent Third Party (including a testing laboratory
424B7
FENC
Fennec Pharmaceuticals Inc
15 Mar 24
Prospectus with selling stockholder info
3:53pm
year ended December 31, 2022, have been audited by Haskell & White LLP, independent registered public accounting firm, as set forth in their report … by Haskell & White LLP, independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein
8-K
EX-4.1
w7tdb
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
8-K
p99qs17agdzxheq 4y
12 Jun 23
Submission of Matters to a Vote of Security Holders
6:24pm
424B3
ak3inbnxb9 tk5ycyg
15 Dec 22
Prospectus supplement
5:12pm
8-K
EX-4.1
pd6cfufo3zu867
26 Sep 22
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment
5:03pm
8-K
EX-4.1
32xdjvsam
22 Aug 22
Fennec Pharmaceuticals Closes First $5 Million Investment
9:00am